Family Nurse Practitioner

Farther Finance Advisors LLC acquires 2,518 shares of Elevance Health, Inc. $ELV. October 11, 2026 Key points. * Farther Finance Advisors increased its Elevance Health stake by 27.1% in the third quarter, adding 2,518 shares to hold 11,826 shares valued at approximately $4.6 million. Institutional investors collectively own 89.24% of the company. * Elevance Health shares were trading at $412.51, up 2.9%, with a market capitalization of about $89.5 billion. The company recently reported quarterly earnings of $7.45 per share, beating estimates by $1.24, and revenue of $49.83 billion. * The company paid a quarterly dividend of $1.72 per share, equivalent to an annualized $6.88 dividend and a 1.7% yield. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $441.48. * Interested in Elevance Health? Here are five stocks we like better. Farther Finance Advisors LLC boosted its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 27.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,826 shares of the company's stock after purchasing an additional 2,518 shares during the period. Farther Finance Advisors LLC's holdings in Elevance Health were worth $4,598,000 as of its most recent SEC filing. Other institutional investors have also recently bought and sold shares of the company. Apella Capital LLC increased its position in shares of Elevance Health by 14.5% during the 3rd quarter. Apella Capital LLC now owns 3,357 shares of the company's stock valued at $1,357,000 after purchasing an additional 425 shares during the last quarter. Everhart Financial Group Inc. boosted its holdings in shares of Elevance Health by 4.9% in the 3rd quarter. Everhart Financial Group Inc. now owns 1,621 shares of the company's stock worth $630,000 after buying an additional 76 shares during the last quarter. Avidian Wealth Enterprises LLC boosted its holdings in shares of Elevance Health by 14.7% in the 3rd quarter. Avidian Wealth Enterprises LLC now owns 797 shares of the company's stock worth $310,000 after buying an additional 102 shares during the last quarter. Toth Financial Advisory Corp boosted its holdings in shares of Elevance Health by 6.9% in the 3rd quarter. Toth Financial Advisory Corp now owns 6,398 shares of the company's stock worth $2,488,000 after buying an additional 414 shares during the last quarter. Finally, Whalen Wealth Management Inc. grew its position in Elevance Health by 3.2% during the third quarter. Whalen Wealth Management Inc. now owns 1,098 shares of the company's stock valued at $427,000 after buying an additional 34 shares during the period. Institutional investors own 89.24% of the company's stock. Elevance Health trading up 2.9%. ELV opened at $412.51 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.68. Elevance Health, Inc. has a 52 week low of $274.84 and a 52 week high of $436.24. The stock has a market cap of $89.46 billion, a PE ratio of 18.33, a PEG ratio of 2.14 and a beta of 0.70. The business has a 50 day moving average of $400.27 and a 200-day moving average of $381.17. Discover more MarketBeat Pro subscription MarketBeat All Access Stock research tools Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings results on Wednesday, July 15th. The company reported $7.45 earnings per share for the quarter, topping the consensus estimate of $6.21 by $1.24. The company had revenue of $49.83 billion for the quarter, compared to analysts' expectations of $48.88 billion. Elevance Health had a return on equity of 14.64% and a net margin of 2.47%. The firm's revenue for the quarter was up .8% on a year-over-year basis. During the same period in the prior year, the firm earned $8.84 earnings per share. Equities research analysts predict that Elevance Health, Inc. will post 27.22 earnings per share for the current fiscal year. Elevance Health announces dividend. The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Thursday, September 10th were issued a dividend of $1.72 per share. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date was Thursday, September 10th. Elevance Health's payout ratio is 30.58%. Analysts set new price targets. ELV has been the subject of several research reports. Wall Street Zen lowered shares of Elevance Health from a "buy" rating to a "hold" rating in a research report on Sunday, July 12th. Raymond James Financial set a $450.00 price objective on shares of Elevance Health in a research report on Tuesday, July 7th. Wells Fargo & Company lowered their price objective on shares of Elevance Health from $492.00 to $473.00 and set an "overweight" rating on the stock in a research report on Thursday, July 16th. Sanford C. Bernstein set a $488.00 target price on shares of Elevance Health in a research note on Thursday, July 16th. Finally, The Goldman Sachs Group reissued a "neutral" rating and set a $395.00 target price on shares of Elevance Health in a research report on Thursday, July 16th. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $441.48. Elevance Health profile. Elevance Health, Inc NYSE: ELV is a health benefits and services company that provides health insurance, managed care and related healthcare solutions in the United States. Its offerings serve individuals, employers, government-sponsored programs and other organizations across commercial, Medicare and Medicaid markets. The company operates a portfolio of health plans, including Blue Cross Blue Shield-affiliated plans in several states, as well as government-focused plans marketed under brands such as Wellpoint. Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Elevance Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elevance Health wasn't on the list. While Elevance Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Continue following MarketBeat

Elevance will stop paying hospital rates for some off-campus clinic care, a shift that could trim facility fees. Published Sep 30, 2026 9:39 PM EDT By Cole Mercer Elevance Health, the insurer behind Anthem plans, said Sept. 29 that it will stop paying hospital rates for certain care delivered at hospital-owned clinics located away from the main hospital campus. According to the company's announcement of new billing transparency policies, those services will instead be paid at the lower off-campus rate. The policies will roll out during 2026 and 2027 across its commercial, Medicare Advantage, and Medicaid plans. The change targets a billing practice that surprises many families. When a hospital system buys a neighborhood doctor's office, the same visit with the same doctor can be billed as hospital outpatient care, often with an added facility fee. Elevance, whose companies serve about 104 million people, said one member's bill rose to more than 10 times the normal amount because of this kind of billing. For households, the concern is practical. Higher payments flow into deductibles, coinsurance, and premiums, so a routine visit, lab test, or imaging scan can cost more depending on who owns the building rather than what care was provided. Same doctor, same visit, higher bill. Site-of-care billing refers to paying a claim based on where care happens. Medicare and many commercial plans have long paid more for services in a hospital outpatient department than in an independent physician's office. Hospitals say facility fees help pay for round-the-clock staffing, equipment, and stricter regulatory standards. The problem arises when a clinic miles from the hospital is registered as a hospital department. Patients may receive two bills, one from the physician and one for the facility, even though the office looks and works like any other practice. Claims have not always shown clearly where care actually took place. The costs add up nationally. Elevance cited a 2023 Blue Cross Blue Shield Association analysis finding that, for four common services, Medicare paid an additional $2.7 billion and patients paid $411 million more out of pocket over three years when the services were delivered in hospital outpatient settings instead of physician offices. Federal health spending data show hospital care reached about $1.6 trillion in 2024, roughly 31% of U.S. health spending. Inside Elevance's new billing rules. Under the new policies, hospitals must identify the physical location where care was provided. Elevance will check billing information against hospital addresses, pay certain off-campus services at the off-campus rate, and block higher hospital billing for some lab tests performed elsewhere. The company says it is the first commercial insurer to announce that it will require location on billing forms. Elevance announced the policies at the Make America Healthy Again (MAHA) Summit in Washington. "These changes will give us better information to help us pay accurately and support our work to make health care more affordable," said Dr. Catherine Gaffigan, president of health solutions at Elevance. "Increasingly, our customers demand affordability, and we have a responsibility to deliver that to them," she said, adding that the actions will help the company address wasteful spending and manage premiums. The move follows state and federal action. Elevance noted that Indiana and Maine have strengthened billing requirements for off-campus care. Separately, a provision in a bipartisan spending law Congress passed earlier this year will require off-campus hospital departments to bill under their own unique National Provider Identifier numbers starting in 2028, Fierce Healthcare reported. States are also enforcing disclosure rules. On Sept. 25, Maryland Attorney General Anthony G. Brown announced that the University of Maryland Medical System would pay $2,251,781.52 in restitution to certain patients who paid out-of-pocket facility fees at some of its hospital clinics before the state's Facility Fee Right-to-Know Act took effect on July 1, 2021. The health system denied that patients had been inadequately informed but agreed to the settlement. Eligible patients should receive refund checks over the next six months. Savings could be modest, and key details are missing. Independent analysts welcomed the direction but cautioned against expecting large savings. Loren Adler, a fellow and associate director of the Brookings Institution's Center on Health Policy, told Axios that the policy should lower prices, but "the magnitude is unlikely to be terribly large." He also said he did not have a good sense of why insurers had not acted sooner. Important questions remain unanswered. Elevance's announcement does not list which services are affected, which states or plans will see changes first, exact start dates, or how much member cost sharing will fall. It also does not say whether hospitals will be barred from billing patients separately for facility fees that Elevance declines to pay at hospital rates. Hospital groups have long defended facility fees as necessary to support hospital infrastructure, so lower payments could become a point of tension in contract negotiations. Protecting yourself from surprise facility fees. People with Anthem or other Elevance plans do not need to take immediate action, since the changes phase in through 2027. Still, patients can reduce surprises now. Before a nonemergency visit, ask whether the clinic is hospital-owned and whether a separate facility fee applies. Review each explanation of benefits for two charges on the same date, one professional and one facility. If your doctor's office was recently bought by a health system, compare your costs before and after. Ask whether lab work or imaging can be done at an independent site, which may cost less. If a bill seems wrong, call your insurer and ask for an itemized statement. Maryland residents can contact the attorney general's Health Education and Advocacy Unit for help with billing disputes, and many states offer similar consumer help lines. Patients who struggle to pay can ask about financial assistance, which nonprofit hospitals must offer under federal tax rules. Elevance's changes move billing toward paying for care based on where it actually happens, but how much families will save remains unclear until the company releases service lists and effective dates. Key questions answered. What is Elevance changing? It will require hospitals to report where care took place and will pay certain services at hospital-owned off-campus clinics at off-campus rates instead of higher hospital rates. What is a facility fee? A facility fee is a charge a hospital adds for the use of its space, staff, and equipment. It is often billed separately from the doctor's fee, even at clinics away from the main hospital. When will members see changes? Elevance says the policies will roll out during 2026 and 2027. It has not published specific dates by service or state. Will my out-of-pocket costs drop? Possibly, but Elevance has not said by how much. A Brookings health policy expert expects the overall effect on prices to be modest. How can I avoid a surprise facility fee? Ask before a visit whether the clinic is hospital-owned and whether a separate facility fee applies, and review each explanation of benefits. Who is getting money back in Maryland? Certain patients who paid out-of-pocket facility fees at some University of Maryland Medical System hospital clinics before July 1, 2021, will receive refunds under a settlement announced Sept. 25. Published by Medicaldaily.com

Strive Health expands executive team to support next phase of growth. New leaders bring deep healthcare expertise across operations, provider networks and enterprise growth Susan Ray, Chief Operating Officer; Sarah Berry, Ph.D., Chief Network & Engagement Officer; Dan Heslin, Chief Growth Officer. DENVER-(BUSINESS WIRE)-Strive Health, the national leader in value-based kidney care, today announced three additions to its executive leadership team to expand its national footprint and deepen its partnerships with payors and providers. Susan Ray has joined Strive as Chief Operating Officer (COO), Sarah Berry, Ph.D., as Chief Network & Engagement Officer (CNEO) and Dan Heslin as Chief Growth Officer (CGO). Together, they will lead three critical areas of Strive's next phase of growth: delivering its care model consistently at scale, strengthening the performance and engagement of its national provider network and expanding access to value-based kidney care through new and existing partnerships. "Scaling value-based care requires strong execution, deeply engaged provider partners and solutions that deliver value for our patients and customers," said Paul Marchetti, Strive's President. "Susan, Sarah and Dan bring proven expertise in building and leading complex healthcare organizations. Their leadership will help us continue to improve how care is delivered for people with kidney disease and comorbidities as we reach more patients nationwide." As COO, Ray will lead Strive's market operations and central services, overseeing customer relationships and the teams responsible for executing the company's care model at the point of delivery. Ray brings deep experience across value-based care, operations, client management and organizational transformation. Most recently, she served as COO of Rippl Care, where she helped build and scale a care model for individuals living with dementia. She previously held senior leadership roles at Honest Health, naviHealth, Evolent Health and Accolade. Berry will oversee the company's network of more than 6,500 provider partners as CNEO, along with engagement functions that connect patients with timely local care and Strive's clinical and social needs programs. Berry most recently served as SVP of clinical service operations at Ventricle Health, where she led the scaling and performance of its advanced heart failure cardiology network and clinical operations. Previously, she held senior network and operational leadership roles at Aetna (a CVS Health Company), Innovation Health and Evolent Health. As CGO, Heslin will lead Strive's business development strategy, strategic partnerships, marketing and market expansion, with a focus on bringing the company's population health solutions and partnerships across payors, providers and other healthcare organizations. Heslin joins Strive following an extensive career at Elevance Health, where he held leadership roles spanning enterprise growth, product strategy and business development and most recently served as president of the company's specialty business. Earlier in his career, he held roles at Roche Diagnostics and in technology strategy consulting. The appointments strengthen Strive's leadership across the full lifecycle of its value-based care model - from building new partnerships and engaging provider networks, to delivering care consistently for patients and customers nationwide. ABOUT STRIVE HEALTH Strive Health is the nation's leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology - including AI - care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 165,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive's case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier(TM), is certified by HITRUST. To learn more, visit StriveHealth.com. More News From Strive Health DENVER-( BUSINESS WIRE )-Strive Health, the leading U.S. value-based kidney care company, was named one of the World's Top HealthTech Companies by TIME and Statista Inc. for a second consecutive year. The full award list can be viewed on Time.com.The World's Top HealthTech Companies 2026 ranking recognizes leading innovators that are advancing healthcare with the support of technology. Out of thousands of healthcare technology companies reviewed, the top 500 were honored. Companies were evaluate... DENVER-( BUSINESS WIRE )-Strive Health, the national leader in value-based kidney care, has welcomed two new members to its executive team. Jamie Sharp, M.D., has been named chief medical officer and will oversee Strive's clinical strategy and performance. Serving as chief financial officer, Chris Rigg will drive financial strategy and operations, while helping scale the business and deploy AI technologies."As Business Wire, Inc. continue to build on Strive's strong momentum, Jamie and Chris stood out as the rig... DENVER-( BUSINESS WIRE )-Strive Health, the national leader in value-based kidney care, welcomes Keith Bellovich, D.O., as its Chief Nephrologist. In this role, Dr. Bellovich will partner with the Chief Clinical Officer and other clinical leadership to drive the development of clinical programs, establish best-practice protocols and oversee a team of providers dedicated to delivering high-quality, evidence-based care for people living with kidney disease. "Dr. Bellovich brings exactly the combi... Strive Health. Release Versions